Skip to content
Chemist Prices

Priligy: UK Status and Risks

Priligy is not UK-licensed for any use in the UK. It may still appear in some catalogs, but its safety and effectiveness have not been assessed by the MHRA.

Consult a qualified clinician before relying on it, and question sellers who make bold claims about it. An unclear licensing status is itself worth asking about.

Not UK-licensed. This medicine is not supplied through UK-registered pharmacies.

Sellers list the active ingredient as dapoxetine. The MHRA has not assessed what these products actually contain.

The MHRA warns that medicines sold outside registered pharmacies can be counterfeit, contaminated, or contain the wrong amount of active ingredient. Buy prescription-only medicines from a pharmacy registered in the UK.

Pharmacies by area for Priligy (UK-licensed equivalent)

Pharmacies near you

Use your location to open the pharmacies closest to you and ask them about Priligy, the UK-licensed medicine with the same active ingredient.

Find pharmacies near me

Cities with the most pharmacies

About Priligy

Priligy is not a licensed medicine in the United Kingdom and cannot legally be sold there as a medicine. Its active ingredient, pharmacological class, formulation and claimed strengths are not specified in the product description.

This limits assessment of its intended use, effects and safety. A doctor or pharmacist can discuss treatment options appropriate to the condition being considered.

Claimed strengths are manufacturer claims; no claimed strength is listed for Priligy. No dosage form or dosing schedule is documented either.

These omissions prevent a meaningful comparison of strength or formulation with recognised treatments. The product name does not establish the amount or identity of any active ingredient.

How Priligy works

Priligy has no specified active ingredient or pharmacological class in its product description, so a mechanism of action cannot be established. Medicines act in different ways, depending on their ingredients, such as altering chemical signalling or affecting processes within cells.

Assigning any particular mechanism to this product would imply knowledge of its contents that has not been established. Its name alone is not sufficient to determine how it might affect the body, whether it would have a therapeutic effect, or which adverse effects might occur.

What Priligy is used for

A marketed treatment claim is not specified for Priligy in its product description. There is therefore no documented indication to describe as either a manufacturer claim or an established medical use. The product name alone does not establish what the preparation contains or which condition it is intended to address.

Any advertising claim should be considered separately from evidence of effectiveness and regulatory approval. A doctor or pharmacist can discuss recognised treatment options for the concern prompting interest in this product.

Key warnings

  • Priligy lacks licensing as a medicine in the United Kingdom, and its contents and quality lack independent verification.
  • The active ingredient and pharmacological class are not specified, preventing a reliable safety assessment.
  • No formulation or strength is listed, so the identity and amount of any active substance are unclear.
  • Unspecified ingredients make adverse effects and contraindications difficult to assess.

Main interactions

  • Specific medicine interactions cannot be identified because the active ingredient is not specified.
  • Compatibility with alcohol cannot be established for this product.
  • Compatibility with herbal remedies and supplements cannot be established.
  • A pharmacist would need a confirmed ingredient list to assess interactions with existing medicines.

Storage

No storage conditions or dosage form are listed for Priligy. General precautions include keeping products out of the sight and reach of children and retaining the original packaging. Formulation-specific storage requirements cannot be established.

Missed dose

No missed-dose guidance can be established for Priligy because its active ingredient, formulation and dosing schedule are not specified. Instructions for another medicine should not be assumed to apply to this product. A doctor or pharmacist can clarify medication-specific guidance once the contents are confirmed.

Pregnancy and breastfeeding

The marketing material does not specify pregnancy or breastfeeding data for Priligy. Its active ingredient is also unspecified, so potential effects on pregnancy, a breastfed child or milk production cannot be assessed. Suitability during pregnancy or breastfeeding should be discussed with a doctor or pharmacist.

Related medicines

First published October 2, 2026 · Last updated · Report an error on this page